Cytimmune Sciences
Cytimmune Sciences is a biotechnology company focused on developing novel technologies to treat solid tumor cancers. Their IO+ platform aims to transform hot tumors into cold ones, reshape the tumor environment, and eliminate cancer cells through various mechanisms. The company's lead therapeutic, CYT-6091, is advancing to phase 2 clinical studies at the National Cancer Institute after demonstrating promising results in phase 1 trials. Cytimmune collaborates with global partners, including academic institutions and government agencies, to advance their innovative therapies in the field of oncology and immunology.
Cytimmune Sciences
Cytimmune Sciences is a biotechnology company focused on developing novel technologies to treat solid tumor cancers. Their IO+ platform aims to transform hot tumors into cold ones, reshape the tumor environment, and eliminate cancer cells through various mechanisms. The company's lead therapeutic, CYT-6091, is advancing to phase 2 clinical studies at the National Cancer Institute after demonstrating promising results in phase 1 trials. Cytimmune collaborates with global partners, including academic institutions and government agencies, to advance their innovative therapies in the field of oncology and immunology.
cytimmune.com
15010 Broschart Road Rockville, Maryland 20850, US
Details
Year founded
2005
Revenue
0-500K
Employees
11-50
Number of locations
1
NAICS
541714
SIC
8731
Products & Services
Outlines the company's specialized services and operational strengths.
- Antibodies
- CYT-6091
- Combination cancer treatments
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Gold nanoparticles for IO+ platform
- TNF alpha delivery system
- CYT-6091 first generation therapeutic construct
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that cytimmune sciences is ramping up production.
Target industries
News
Nanomedicine Industry to Witness Massive Growth (2024-2031) |
Nanomedicine Industry to Witness Massive Growth (2024-2031) |
Press release - DataM Intelligence - Nanomedicine Industry to Witness Massive Growth (2024-2031) | Pfizer Inc., CytImmune Sciences, Ablynx (Sanofi S.A.),...
Locations (1)
Cytimmune Sciences
15010 Broschart Road Rockville, Maryland 20850, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does Cytimmune Sciences offer?
Cytimmune Sciences offers a range of services and capabilities, including Antibodies.
What kind of equipment does Cytimmune Sciences use?
Cytimmune Sciences uses a variety of equipment, including Gold nanoparticles for IO+ platform.
What are the target industries of Cytimmune Sciences?
Cytimmune Sciences serves several industries, including the medical industry.
How many locations does Cytimmune Sciences operate?
Cytimmune Sciences operates from a single location at 15010 broschart road, rockville, maryland 20850, united states.
Where are the headquarters of Cytimmune Sciences?
The headquarters of Cytimmune Sciences are located in 15010 broschart road, rockville, maryland 20850, united states.
What is the NAICS code for Cytimmune Sciences?
The NAICS code for Cytimmune Sciences is 541714.
How many employees does Cytimmune Sciences have?
Cytimmune Sciences has 12 employees.
What is the official website of Cytimmune Sciences?
The official website of Cytimmune Sciences is https://www.cytimmune.com/.
When was Cytimmune Sciences founded?
Cytimmune Sciences was founded in 2005.